HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Permanent decrease in activity of ornithine decarboxylase antizyme in rat liver during chemical hepatocarcinogenesis.

Abstract
This study was undertaken to determine whether or not there is failure of cellular control of L-ornithine decarboxylase activity by its antizyme, the only known natural intracellular inhibitor protein for L-ornithine decarboxylase activity, in rat liver during hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene. The formation of hepatic ornithine decarboxylase antizyme was elicited by i.p. injections of putrescine into rats fed a basal diet and rats fed the carcinogenic diet. The activities of both hepatic ornithine decarboxylase and hepatic ornithine decarboxylase antizyme were measured every month for five months, i.e., until hepatoma was fully developed. During azo-dye hepatocarcinogenesis and in fully developed hepatoma the activity of hepatic ornithine decarboxylase antizyme was always significantly lower than in normal resting liver, with minima at the second and the third months. The hepatoma does not synthesize ornithine decarboxylase antizyme more slowly than normal liver, since the difference could be neither abolished nor lessened by lengthening the time available for antizyme formation. Our results strongly suggest that the high intracellular putrescine levels in the livers of rats during 3'-methyl-4-dimethylaminoazobenzene hepatocarcinogenesis do not exert their normal control on hepatic ornithine decarboxylase activity because of a relative inability of these preneoplastic or neoplastic cells to make the ornithine decarboxylase antizyme.
AuthorsD Modena, M E Ferioli, G Scalabrino
JournalCarcinogenesis (Carcinogenesis) Vol. 4 Issue 12 Pg. 1659-62 (Dec 1983) ISSN: 0143-3334 [Print] England
PMID6652875 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ornithine Decarboxylase Inhibitors
  • Proteins
  • ornithine decarboxylase antizyme
  • Methyldimethylaminoazobenzene
Topics
  • Animals
  • Kinetics
  • Liver (drug effects, enzymology)
  • Liver Neoplasms, Experimental (chemically induced, enzymology)
  • Male
  • Methyldimethylaminoazobenzene (toxicity)
  • Ornithine Decarboxylase Inhibitors
  • Proteins (metabolism)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: